Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: Microglial activation-dependent and -independent regulations

Toxicological Sciences

Volumn 122, Issue 2, 2011, Pages 526-538

  Singh, Anand Kumar ^a   Tiwari, Manindra Nath ^a   Dixit, Anubhuti ^a   Upadhyay, Ghanshyam ^a   Patel, Devendra Kumar ^a   Singh, Dhirendra ^a   Prakash, Om ^b   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cypermethrin; Microglial activation; Neurodegeneration; Proteomics

Indexed keywords

ALPHA INTERNEXIN INTERMEDIATE FILAMENT; CIPERMETHRIN; CONNEXIN 47; DOPAMINE; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; MEMBRANE PROTEIN; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE ACTIVATED KINASE 5; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 1; PLATELET ACTIVATING FACTOR ACETYL HYDROLASE 1B ALPHA2; PROHIBITIN; PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEINASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; STATHMIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; TYROSINE 3 MONOOXYGENASE; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NEURODEGENERATION; MALE; MICROGLIA; MOTOR DYSFUNCTION; NERVE DEGENERATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RAT; SUBSTANTIA NIGRA;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; INTERMEDIATE FILAMENT PROTEINS; MALE; MASS SPECTROMETRY; MICROGLIA; NERVE DEGENERATION; PHENOTYPE; PROTEOMICS; PYRETHRINS; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

EID: 80051700456     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr115     Document Type: Article

References (43)

1. Barbeau, A., Roy, M., and Bernier, G. (1987). Ecogenetics of Parkinson's disease: prevalence and environmental aspects in rural areas. Can. J. Neurol. Sci. 14, 36-41.
2. Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B., Lopiano, L., and Fasano, M. (2004). Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4, 3943-3952.
3. Bradberry, S. M., Cage, S. A., Proudfoot, A. T., and Vale, J. A. (2005). Poisoning due to pyrethroids. Toxicol. Rev. 24, 93-106.
4. Cairns, N. J., Zhukareva, V., Uryu, K., Zhang, B., Bigio, E., Mackenzie, I. R., Gearing, M., Duyckaerts, C., Yokoo, H., Nakazato, Y., et al. (2004). a-Internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. Am. J. Pathol. 164, 2153-2161.
5. Casida, J. E., and Quistad, G. B. (1998). Golden age of insecticide research: past, present, or future? Annu. Rev. Entomol. 43, 1-16.
6. Ching, G. Y., Chien, C. L., Flores, R., and Liem, R. K. (1999). Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice. J. Neurosci. 19, 2974-2986.
7. Cicchetti, F., Lapointe, N., Roberge-Tremblay, A., Saint-Pierre, M., Jimenez, L., Ficke, B. W., and Gross, R. E. (2005). Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiol. Dis. 20, 360-371.
8. DiDomenico, F., Sultana, R., Tiu, G. F., Scheff, N. N., Perluigi, M., Cini, C., and Butterfield, D. A. (2010). Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res. 1333, 72-78.
9. Dong, Z., Wolfer, D. P., Lipp, H., and Bueler, H. (2006). Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease. Mol. Ther. 11, 80-88.
10. Eves, E. M., Shapiro, P., Naik, K., Klein, U. R., Trakul, N., and Rosner, M. R. (2006). Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol. Cell 23, 561-574.
11. Finehout, E. J., Franck, Z., Choe, L. H., Relkin, N., and Lee, K. H. (2007). Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann. Neurol. 61, 120-129.
12. Giampirtro, C., Luzzati, F., Gambarotta, G., Giacobini, P., Boda, E., Fasolo, A., and Perroteau, I. (2005). Stathmin expression modulates migratory properties of GN-11 neurons in vitro. Endocrinology 146, 1825-1834.
13. Giray, B., Gurbay, A., and Hincal, F. (2001). Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol. Toxicol. Lett. 118, 139-146.
14. Harbour, J. W., and Dean, D. C. (2000). The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 14, 2393-2409.
15. He, Y., Appel, S., and Le, W. (2001). Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 909, 187-193.
16. Heudorf, U., Angerer, J., and Drexler, H. (2004). Current internal exposure to pesticides in children and adolescents in Germany: urinary levels of metabolites of pyrethroid and organophosphorus insecticides. Int. Arch. Occup. Environ. Health 77, 67-72.
17. Hodel, A. (1998). SNAP-25. Int. J. Biochem. Cell Biol. 30, 1069-1073.
18. Hu, X., Shi, Q., Zhou, X., He, W., Yi, H., Yin, X., Gearing, M., Levey, A., and Yan, R. (2007). Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO J. 26, 2755-2767.
19. Ideker, T., Galitski, T., and Hood, L. (2001). A new approach to decoding life: systems biology. Annu. Rev. Genomics Hum. Genet. 2, 343-372.
20. Jin, K., Mao, X. O., Cottrell, B., Schilling, B., Xie, L., Row, R. H., Sun, Y., Peel, A., Childs, J., Gendeh, G., and et al. (2004). Proteomic and immunochemical characterization of a role for stathmin in adult neurogenesis. FASEB J. 18, 287-299.
21. Kale, M., Rathore, N., John, S., and Bhatnagar, D. (1999). Lipid peroxidative damage on pyrethroid exposure and alterations in antioxidant status in rat erythrocytes: a possible involvement of reactive oxygen species. Toxicol. Lett. 105, 197-205.
22. Koller, W., Vetere-Overfield, B., and Gray, C. (1990). Environmental risk factors in Parkinson's disease. Neurology 40, 1218-1221.
23. Li, X., Wang, H., Qiu, P., and Luo, H. (2008). Proteomic profiling of proteins associated with methamphetamine-induced neurotoxicity in different regions of rat brain. Neurochem. Int. 52, 256-264.
24. Logroscino,G. (2005).The role of early life environmental risk factors in Parkinson disease: what is the evidence? Environ. Health Perspect 113, 1234-1238.
25. LoPachin, R. M., Jones, R. C., Patterson, T. A., Slikker, W. J., and Barber, D. S. (2003). Application of proteomics to the study of molecular mechanisms in neurotoxicology. Neurotoxicology 24, 761-775.
26. Nagya, J. I., Lia, W., Hertzbergb, E. L., and Marotta, C. A. (1996). Elevated connexin-43 immunoreactivity at sites of amyloid plaques in Alzheimer's disease. Brain Res. 717, 173-178.
27. Obin, M., Shang, F., Gong, X., Handelman, G., Blumberg, J., and Taylor, A. (1998). Redox regulation of ubiquitin-conjugating enzymes: mechanistic insights using the thiol-specific oxidant diamide. FASEB J. 12, 561-569.
28. Orellana, J. A., Saez, P. J., Shoji, K. F., Schalper, K. A., Palacios-Prado, N., Velarde, V., Giaume, C., Bennett,M. V., and Saez, J. C. (2009).Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid. Redox. Signal. 11, 369-399.
29. Otsu, M., Urade, R., Kito, M., Omura, F., and Kikuchi, M. A. (1995). A possible role of ER-60 protease in the degradation of misfolded proteins in the endoplasmic reticulum. J. Biol. Chem. 270, 14958-14961.
30. Patel, S., Singh, K., Singh, S., and Singh, M. P. (2008). Gene expression profiles of mouse striatum in control and maneb ± paraquat-induced Parkinson's disease phenotype: validation of differentially expressed energy metabolizing transcripts. Mol. Biotechnol. 40, 59-68.
31. Patel, S., Singh, V., Kumar, A., Gupta, Y. K., and Singh, M. P. (2006). Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration. Brain Res. 1081, 9-18.
32. Patel, S., Sinha, A., and Singh, M. P. (2007). Identification of differentially expressed proteins in striatum of maneb-and paraquat-induced Parkinson's disease phenotype in mouse. Neurotoxicol. Teratol. 29, 578-585.
33. Saint-Pierre, M., Tremblay, M. E., Sik, A., Gross, R. E., and Cicchetti, F. (2006). Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats. J. Neurochem. 98, 760-772.
34. Singh,A.K.,Tiwari, M.N.,Upadhyay,G., Patel,D.K., Singh,D., Prakash,O., and Singh, M. P. (2010). Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol. Aging. Advance Access published on April 3, 2010; doi:10.1016/j.neurobiolaging.2010.02.018.
35. Sinha, A., Srivastava, N., Singh, S., Singh, A. K., Bhushan, S., Shukla, R., and Singh, M. P. (2009). Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach. Clin. Chim. Acta. 400, 14-20.
36. Srivastava, G., Singh, K., Tiwari, M. N., and Singh, M. P. (2010). Proteomics in Parkinson's disease: current trends, translational snags and future possibilities. Expert Rev. Proteomics 7, 127-139.
37. Thiruchelvam, M., Richfield, E. K., Goodman, B. M., Baggs, R. B., and Cory-Slechta, D. A. (2002). Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23, 621-633.
38. Tiwari, M. N., Singh, A. K., Ahmad, I., Upadhyay, G., Singh, D., Patel, D. K., Singh, C., Prakash, O., and Singh, M. P. (2010). Effects of cypermethrin on monoamine transporters, xenobiotic metabolizing enzymes and lipid peroxidation in the rat nigrostriatal system. Free Radic. Res. 44, 1416-1424.
39. Tribl, F., Asan, E., Arzberger, T., Tatschner, T., Langenfeld, E., Meyer, H. E., Bringmann, G., Riederer, P., Gerlach, M., and Marcus, K. (2009). Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach. Mol. Cell. Proteomics 8, 1832-1838.
40. Tsai, J. W., Chen, Y., Kriegstein, A. R., and Vallee, R. B. (2005). LIS1 RNA interference blocks neural stem cell division, morphogenesis and motility at multiple stages. J. Cell Biol. 170, 935-945.
41. Werner, C. J., Heyny-von Haussen, R., Mall, G., and Wolf, S. (2008). Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci. 6, 8.
42. Witt, S. N. (2010). Hsp70 molecular chaperones and Parkinson's disease. Biopolymers 93, 218-228.
43. Ying, W., Wei, G., Wang, D., Wang, Q., Tang, X., Shi, J., Zhang, P., and Lu, H. (2007). Intranasal administration with NAD+ profoundly decreases brain injury in a rat model of transient focal ischemia. Front. Biosci. 12, 2728-2734.